Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/22/2025

Management of COPD Not Controlled on Trelegy

Assessment of Current Therapy

  • Up to 76% of COPD patients make important errors when using their inhalers, highlighting the need for proper inhaler technique verification, according to the British Thoracic Society 1
  • The diagnosis of COPD should be verified and other conditions ruled out to ensure accurate treatment, as recommended by the European Respiratory Society 2
  • Current symptoms and limitations should be properly documented to establish a baseline for future assessments, as suggested by the American Thoracic Society 2

Therapeutic Options When Triple Therapy is Insufficient

Evaluate for Home Nebulizer Therapy

  • High-dose bronchodilator treatment via nebulizer may provide additional benefit for patients with severe disease who remain symptomatic, according to the National Institute for Health and Care Excellence 3
  • Formal assessment by a respiratory physician is necessary before prescribing home nebulizer therapy, as recommended by the British Thoracic Society 3
  • Assessment should include verification of optimal use of current inhalers and response to nebulized medication, as suggested by the European Respiratory Society 3

Consider Theophyllines

  • Theophyllines can be tried in patients with severe COPD not responding to other therapies, but require careful monitoring for side effects, as recommended by the American College of Chest Physicians 4
  • Theophyllines may improve respiratory muscle strength and effectiveness, which could explain improvements in exercise tolerance, according to the European Respiratory Society 1

Management of Acute Exacerbations

  • Increase the dose of current bronchodilators during an acute exacerbation, as recommended by the Global Initiative for Chronic Obstructive Lung Disease 2
  • Consider adding oral corticosteroids (typically 30mg daily for one week) if the patient is already on oral corticosteroids, has a previously documented response, or airflow obstruction fails to respond to increased bronchodilator dose, as suggested by the American Thoracic Society 2
  • Prescribe antibiotics if two or more of the following are present: increased breathlessness, increased sputum volume, or development of purulent sputum, according to the Infectious Diseases Society of America 2

Non-Pharmacological Approaches

  • Encourage appropriate exercise within the limitations of the patient's airways obstruction, as recommended by the American Thoracic Society 4
  • Consider nutritional support if the patient is malnourished, as malnutrition is common in severe COPD and may contribute to mortality, according to the European Respiratory Society 4
  • Ensure the patient has received influenza and pneumococcal vaccinations, as recommended by the Centers for Disease Control and Prevention 4

Common Pitfalls to Avoid

  • Avoid beta-blocking agents (including eyedrop formulations) in COPD patients, as recommended by the American Heart Association 4
  • Discontinue ineffective medications to avoid unnecessary side effects and costs, as suggested by the National Institute for Health and Care Excellence 5
  • Avoid prescribing high-dose treatments, including nebulized drugs, without formal assessment, according to the British Thoracic Society 4

Follow-up and Monitoring

  • Regular follow-up is essential to assess response to therapy and adjust treatment as needed, as recommended by the American Thoracic Society 2
  • Consider referral to a specialist for further evaluation if the patient fails to respond to additional therapies, according to the European Respiratory Society 2
  • Monitor for side effects of added medications, particularly with theophyllines, as suggested by the American College of Chest Physicians 4